Company intelligence / Profile preview

Thynk Capital

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Thynk Capital is a privately owned investment group founded by entrepreneur and investor Jim Plante, focused on early-stage therapeutics, healthcare and technology companies, with a particular emphasis on extending healthspan and addressing major diseases of aging. It invests primarily in early-stage, capital-efficient pharma and biotech companies, typically at pre-clinical or early clinical stages, and works hands-on with portfolio companies.

Industry: Investors

Beyond the preview

Go deeper on Thynk Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thynk Capital.

Explore the full profile